Development of monoclonal antibody therapy [ 2013 - 2016 ]

Research Grant

Researchers: A/Pr Daniel Christ (Principal investigator)

Brief description Monoclonal antibodies, such as the breast cancer therapeutic Herceptin, have revolutionised the treatment of cancer and inflammatory conditions. Will over $30 billion sales in 2011, they have also spawned a growing biotech industry. We have a generated a highly specific monoclonal antibody, which has shown efficacy in models of disease. This project will further advance and develop this monoclonal, allowing us to initiate clinical studies in patients.

Funding Amount $AUD 459,270.32

Funding Scheme Career Development Fellowships

Notes Industry CDF